SCHEMBL18326164

SCHEMBL18326164

c1ccc(C2(c3ccc(N(c4ccc(-c5ccc6c(c5)oc5ccccc56)cc4)c4ccc(-c5cccc6ccccc56)cc4)cc3)c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA9 Q16790 2/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
HCRTR1 O43613 1/20 0.32
DUSP3 P51452 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
LMNA P02545 1/20 0.32
OPRK1 P41145 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CHRNB4 P30926 2/20 0.31
CHRNA3 P32297 2/20 0.31
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18326014 0.94 CA12 (0.34) CA12CA1CA2CA9KDM4E
SCHEMBL23769937 0.93 CA12 (0.33) CA12CA1CA2CA9MMP12
SCHEMBL17827462 0.93 CA12 (0.35) CA12CA1CA2CA9MMP12
SCHEMBL17827455 0.93 CA12 (0.35) CA12CA1CA2CA9MMP12
SCHEMBL23238408 0.92 CHRNA1 (0.33) CA12CA1CA2CA9MMP12
SCHEMBL18326179 0.92 MMP12 (0.36) MMP12MMP13HCRTR1KDM4EMEN1
SCHEMBL18326161 0.92 MMP12 (0.37) CA12CA1CA2CA9MMP12
SCHEMBL18326168 0.92 MMP12 (0.37) CA12CA1CA2CA9MMP12
SCHEMBL23237179 0.91 CHRNA1 (0.33) CA12CA1CA2CA9MMP12
SCHEMBL25089309 0.91 MMP12 (0.32) MMP12MMP13HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11563179-B2 Compound, organic optoelectronic element comprising same and display device thereof SAMSUNG SDI CO., LTD. (KR) 2023-01-24 US disclosed
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF SAMSUNG SDI CO., LTD. (KR) 2016-12-22 US disclosed
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF SAMSUNG SDI CO., LTD. (KR) 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF OR10J3, OR51E2, ORMDL3 CA12 338/4885CA1 673/4885CA2 1050/4885
US-11563179-B2 Compound, organic optoelectronic element comprising same and display device thereof OR10J3, OR51E2, ORMDL3 CA12 338/4885CA1 673/4885CA2 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.